
News|Articles|November 1, 2012
Vascepa (Icosapent ethyl)
New molecular entity: FDA approved icosapent ethyl (Vascepa, Amarin Pharmaceuticals Ireland Limited), an ethyl ester of eicosapentaenoic acid (EPA), as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Will the end of enhanced ACA subsidies mean the beginning of a health insurance crisis?
2
Many PCPs unaware of current ACIP shingles vaccine guidance, study finds
3
Pharmacy leaders in ASHP survey worry about 340B program changes
4
FDA approves first postmenopausal libido treatment, Addyi
5


















































